REPLY
13.9.2021 11:32:12 CEST | Business Wire | Press release
Following the success of the first edition and the satisfaction shown by all the students who participated in the training path, and now in working in corporate projects, Reply and the Specializing Master's Programmes and Lifelong Learning School of the Politecnico di Torino announce that enrolment is now open for the second edition of the second-level Master's degree course in "Artificial Intelligence & Cloud Hands-on innovation" .
Starting in January 2022 , the Master’s offers 40 highly qualified students a professional specialisation path in the IT sector through its most innovative technologies: artificial intelligence, machine learning and cloud .
The lessons will be held in person at the Politecnico di Torino and will combine Politecnico di Torino professors and Reply specialists in a mix of theoretical lessons and practical live cases . During the programme, students will work in groups on live projects at Reply , where they will put into practice the knowledge acquired in the classroom.
The Master's is open to students who have previously obtained a Master's degree in either Computer Science, Computer Engineering, Automation Engineering, Telecommunications Engineering, Electronic Engineering and Cybersecurity (the degree must be completed by December 31, 2021). The entire course is in English and it is open to international entrants.
Applications should be submitted online by October 22, 2021 following the instructions available at master.reply.com . This will be followed by an evaluation process in which a commission made up of members of the Politecnico di Torino and Reply professionals will assess the candidates' curricula, educational background and professional experience. The commission will also meet each candidate for an individual interview.
The “Earn While You Learn” formula has also been confirmed for this second edition. Reply commits to hire the selected candidates right from the start of the programme and to bear all the costs of participation in the Master’s for those who accept the job offer.
“Through this specialisation path, in collaboration with the Politecnico di Torino, we aim to create an elite group of students who are highly qualified in the most innovative IT issues and to progressively include these students in our projects” explains Filippo Rizzante, Reply CTO. “Artificial intelligence, machine learning and cloud are fundamental for Reply and for our customers, which is why we want to train students in these technologies right from the start.”
"The Master’s in collaboration with Reply – explains the Specializing Master's Programmes and Lifelong Learning School’s Director, Prof. Paolo Neirotti – is one of the initiatives of excellence that the Master’s School designs and delivers. The programme has a custom-made approach for sector leaders and confirms that the digital transformation requires the various profiles coming out of Master's degrees in Engineering to have hyper-technical specialisation. As a technical university, we are well prepared to provide this specialisation as we design Master's programmes that integrate, recombine and extend the different scientific areas within our second-level training offer. On top of this we also rely on our experience in company applied research and technology."
Politecnico di Torino is recognized as one of the most respected universities in Europe and Reply is a company that has made innovation and technological specialization its flagship. Both entities have joined forces to create a training path for excellence; one aimed at preparing the professionals the industry needs to face the challenges of the future.
More information available at master.reply.com and https://didattica.polito.it/master/ai_cloud/2022/at_a_glance .
°°°
REPLY
Reply [MTA, STAR: REY, ISIN: IT0005282865] specialises in the design and implementation of solutions based on new communication channels and digital media. As a network of highly specialised companies, Reply defines and develops business models enabled by the new models of big data, cloud computing, digital media and the internet of things. Reply delivers consulting, system integration and digital services to organisations across the telecom and media; industry and services; banking and insurance; and public sectors. www.reply.com
Specializing Master's Programmes and Lifelong Learning School of the Politecnico di Torino
The Specializing Master's Programmes and Lifelong Learning School of the Politecnico di Torino was founded in December 2011 with the aim of organising and managing first-level and second-level Master’s programmes, as well as Lifelong Learning courses, including executive courses. The School stands out for the variety and multidisciplinary nature of its Master’s programmes and training courses, which are an expression of the many scientific and cultural areas present within a research university such as the Politecnico di Torino. The training offer proposed by the School covers several disciplinary areas in order to provide support to companies and public and private institutions, so that they develop their transition ability towards new technological, economic and social paradigms (e.g. electrification, sustainability, digital transformation). Consistent with the polytechnic tradition, the scientific areas underpinning the School's continuing education offer are related to Industry 4.0, new forms of mobility, development and technology transfer in aerospace, digital transformation of businesses, public administration and society, environmental and energy sustainability, digitalisation in construction, new approaches and new frontiers in design, and the design of territories in the perspective of resilience.
View source version on businesswire.com: https://www.businesswire.com/news/home/20210913005045/en/
Link:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
KATE Launches "KABUKE: Break Convention" Kabuki-Inspired International Campaign17.7.2026 09:00:00 CEST | Press release
Where “NO MORE RULES.” intersects with the Kabuku spirit. Inspired by Japanese aesthetics, KATE shares the value of shadow enhancing makeup and self‑expression with the world. Global cosmetics brand KATE launched “KABUKE: Break Convention,” a new international campaign drawing on elements of Kabuki, the traditional Japanese performing art. The campaign debuted on Wednesday, July 8, 2026. In this campaign, KATE’s shadow enhancing makeup—rooted in Japanese aesthetics—was paired with the Kabuki spirit inherited from traditional Kabuki theater to communicate the value of individuality and self‑expression through makeup on a global scale. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260708829427/en/ KATE international campaign “KABUKE: Break Convention” key visual. Dedicated website: https://www.kate-global.net/my/special/kate_kabuki/ Since its founding, KATE has championed the slogan “NO MORE RULES.,” offering makeup that defi
Meiji Seika Pharma: Results from the Global Phase III Trial (Integral-2) of Nacubactam, a Novel β-Lactamase Inhibitor, Highlighted in The Lancet Microbe’s Coverage of ESCMID Global Congress 202617.7.2026 03:00:00 CEST | Press release
Meiji Seika Pharma Co., Ltd. (Headquarters: Tokyo, President and Representative Director: Toshiaki Nagasato) today announced that results from the global Phase III trial (Integral-2) of nacubactam (Development Code: OP0595), a novel β-lactamase inhibitor, were highlighted in The Lancet Microbe’s coverage of ESCMID Global Congress 2026 (held in Munich, Germany). As highlighted in The Lancet Microbe’s coverage, the key findings presented by Meiji Seika Pharma at ESCMID Global Congress 2026 are as follows: The Integral-2 study (jRCT2031230076) is a global Phase III clinical trial that enrolled patients with complicated urinary tract infections, acute uncomplicated pyelonephritis, hospital-acquired bacterial pneumonia, ventilator-associated bacterial pneumonia, or complicated intra-abdominal infections caused by carbapenem-resistant Gram-negative bacteria (excluding Acinetobacter species). The study has achieved the prespecified study objectives. For the primary endpoint of overall treatme
Yoshihiro Shimamura Joins the Marché du Film’s “Investors Circle 2026” as an Invited Investor, Backing a New Feature Film17.7.2026 03:00:00 CEST | Press release
Shimamura Yoshihiro Film Production Co., Ltd. (Head office: Osaka, Japan; Representative Director: Yoshihiro Shimamura), a company active in film production and investment, today announced that Representative Director Yoshihiro Shimamura has decided to invest in an international feature film after being invited to the “Investors Circle 2026” — a distinction that reflects his standing as one of the field’s most highly regarded producers and investors. Hosted by the Marché du Film, the business arm of the Festival de Cannes and one of the world’s largest film markets, the Investors Circle is an invitation-only summit that connects a select group of private investors with high-end feature films during early-stage financing. Held in Cannes, France, May 16-17, 2026, it brings internationally acclaimed directors and producers together with investors around a curated slate of projects in development. During the summit, Shimamura attended private pitching sessions and, after individual meeting
Takeda’s Zasocitinib Demonstrates Consistent, High Rates of Skin Clearance Across the Body, Including Hard-to-Treat and High-Impact Sites, in Phase 3 Psoriasis Studies17.7.2026 00:00:00 CEST | Press release
On average, about 75% of patients with scalp psoriasis treated with zasocitinib achieved clear or almost clear skin at week 16 Approximately 70% of patients with palmoplantar disease treated with zasocitinib achieved clear or almost clear skin at week 16 Zasocitinib demonstrated statistically significant improvements in Nail Psoriasis Severity Index (NAPSI) versus placebo Results reinforce the potential of zasocitinib to deliver rapid and durable skin clearance, including in the hardest-to-treat areas, in a convenient once-daily pill Takeda (TSE:4502/NYSE:TAK) announced new data from the two pivotal Phase 3 studies of zasocitinib (TAK-279), a next-generation, highly selective and potent oral tyrosine kinase 2 (TYK2) inhibitor, in adults with moderate-to-severe plaque psoriasis (PsO).1 Presented at the 2026 American Academy of Dermatology (AAD) Innovation Academy, these secondary endpoint data show that zasocitinib demonstrated consistent and high rates of skin clearance across hard-to-
Merz Completes Inaugural €450 Million Schuldschein Loan Issuance16.7.2026 23:36:00 CEST | Press release
Debut transaction more than three times oversubscribed The Merz Group has successfully completed its first-ever Schuldschein loan issuance, placing a total volume of €450 million in the debt capital market – a multiple of three relating to the launch volume. The debut transaction was significantly oversubscribed and attracted strong interest from all investor groups. The proceeds were settled and paid out today. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260716926041/en/ Dr. Almuth Steinkühler, Chief Financial Officer Merz Group The transaction comprises both fixed- and floating-rate tranches with maturities of three, five, seven, and ten years. Around 50 German and international investors participated, representing a broad range of institutions, including private banks, German federal state-owned banks, public savings banks, cooperative banks, pension funds and occupational pension institutions. With the successful plac
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom